sinensetin has been researched along with acacetin in 5 studies
| Studies (sinensetin) | Trials (sinensetin) | Recent Studies (post-2010) (sinensetin) | Studies (acacetin) | Trials (acacetin) | Recent Studies (post-2010) (acacetin) |
|---|---|---|---|---|---|
| 56 | 0 | 42 | 231 | 1 | 159 |
| Protein | Taxonomy | sinensetin (IC50) | acacetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.083 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.1655 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.167 | |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 3.3 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.049 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.6967 | |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | 5.78 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 5.78 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.011 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 5.7 | |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | 9.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
| Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A | 1 |
| Debyser, Z; Glisic, S; Mouscadet, JF; Veljkovic, N; Veljkovic, V | 1 |
| Androutsopoulos, VP; Papakyriakou, A; Spandidos, DA; Vourloumis, D | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
5 other study(ies) available for sinensetin and acacetin
| Article | Year |
|---|---|
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Simple criterion for selection of flavonoid compounds with anti-HIV activity.
Topics: Anti-HIV Agents; Computational Biology; Flavonoids; Humans; Models, Molecular; Quantitative Structure-Activity Relationship | 2007 |
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Topics: Aryl Hydrocarbon Hydroxylases; Binding Sites; Cell Line; Computer Simulation; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Enzyme Inhibitors; Flavones; Flavonoids; Humans; Recombinant Proteins; Substrate Specificity | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |